Monash University study reveals a hesitancy to support widespread use of psilocybin and MDMA due to concerns about poor quality of evidence
Follow our Australia news live blog for latest updates
Get our morning and afternoon news emails, free app or daily news podcast
Evidence to support the widespread use of psychedelics to treat mental health conditions such as depression is lacking, according to politicians and representatives of peak health bodies interviewed for a research paper published on Wednesday.
Researchers from Monash University in Melbourne conducted in-depth interviews with senior experts from a range of organisations involved in psychedelic drug law reform, clinical use or regulation.